Volume | 0 |
|
|||||
Actualités | - | ||||||
Maximum Haut | Bas Haut |
||||||
Minimum Bas |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Quince Therapeutics Inc | QNCX | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
1,055 |
Transactions Totales | Volume échangé | Volume en moyenne | Sur 52 semaines |
---|---|---|---|
0 | 0 | - | 0,84 - 1,74 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
- | 0 | US$ 1,055 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
45,01M | 42,87M | - | 0 | -31,39M | -0,73 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Quince Therapeutics
Date | Heure | Source | Titre |
---|---|---|---|
01/4/2024 | 13:00 | Business Wire | Quince Therapeutics Provides Business Update and Reports.. |
22/2/2024 | 13:00 | Business Wire | Quince Therapeutics Launches Scientific Advisory Board |
15/2/2024 | 22:00 | Edgar (US Regulatory) | Form 8-K - Current report |
15/2/2024 | 13:00 | Business Wire | Quince Therapeutics Appoints Former Reata Pharmaceuticals.. |
07/2/2024 | 22:05 | Business Wire | Quince Therapeutics to Present at Oppenheimer 34th Annual.. |
02/2/2024 | 23:53 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
05/1/2024 | 22:01 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
04/1/2024 | 22:05 | Business Wire | Quince Therapeutics to Participate at Investor Events in.. |
03/1/2024 | 22:02 | Edgar (US Regulatory) | Form 8-K - Current report |
22/12/2023 | 22:08 | Edgar (US Regulatory) | Form 8-K - Current report |
15/12/2023 | 00:21 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
08/12/2023 | 22:06 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Action Quince Therapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Quince Therapeutics Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 1,05 | 1,1199 | 0,98 | 1,07 | 92 024 | 0,005 | 0,48% |
1 mois | 1,06 | 1,1199 | 0,89 | 1,02 | 96 505 | -0,005 | -0,47% |
3 mois | 1,33 | 1,42 | 0,89 | 1,14 | 70 108 | -0,275 | -20,68% |
6 mois | 0,9325 | 1,4301 | 0,84 | 1,11 | 81 138 | 0,1225 | 13,14% |
1 an | 1,53 | 1,74 | 0,84 | 1,23 | 139 166 | -0,475 | -31,05% |
3 ans | 38,18 | 121,98 | 0,5401 | 10,92 | 616 542 | -37,13 | -97,24% |
5 ans | 20,00 | 121,98 | 0,5401 | 15,27 | 433 572 | -18,95 | -94,73% |